No Detail Found!

Combination therapy in pediatric bronchitis: Examining mucolytic, bronchodilator and anti-inflammatory drug effects on secretion management and recovery time

Author(s)
Xuan Zhang Department of Nursing, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan City, Hubei Province,China
Xiaoju Xiong Department of Nursing, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan City, Hubei Province,China
Huiyun Zhu Department of Nursing, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan City, Hubei Province,China
Abstract
s: This study investigated the effectiveness of combining mucolytic agents (ambroxol hydrochloride), bronchodilators (terbutaline sulfate), and anti-inflammatory drugs (budesonide) in treating pediatric bronchitis. From September 2023 to February 2024, 410 pediatric patients were divided into two groups: A control group treated with bronchodilators and anti-inflammatory drugs, and a study group receiving the combined therapy. The results indicated that the study group exhibited significantly better clinical efficacy, with faster resolution of symptoms such as dyspnea, cough, and fever compared to the control group (P<0.05). Pulmonary function indicators, including tidal volume and respiratory ratios, also showed greater improvement in the study group (P<0.05). Additionally, serum levels of inflammatory markers (WBC, CRP, TNF-a, IL-6) were lower in the study group after treatment (P<0.05). Sleep quality improved more in the study group, with longer sleep duration and fewer awakenings (P<0.05). Airway secretion clearance function was also better in the study group, with lower sputum volume and viscosity (P<0.05). No significant difference in adverse reactions was observed between the groups (P>0.05). The findings suggest that the combined therapy of mucolytic agents, bronchodilators and anti-inflammatory drugs is highly effective in treating pediatric bronchitis, offering significant benefits in symptom improvement, pulmonary function enhancement, inflammatory reduction, sleep improvement, and airway clearance.
Publication Details
Page(s) 1221-1230
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
Combination therapy, Recovery time, Anti-Inflammatory Drugs, Bronchodilators, mucolytic agents, pediatric bronchitis, secretion management
References
Andina Martínez D,Claret Teruel G,Gijón Mediavilla M,Cámara Otegui A,Baños López L,de Miguel Lavisier B,Ferrero García-Loygorri C,Sánchez Tatay V,Pavlovic Nesic S,Clerigué Arrieta N,GimenoHernández Garza V,Guerra Diez JL,Ranera Málaga A,Escalada Pellitero S .2024 .Nirsevimab and acute bronchiolitis episodes in pediatric emergency departments. Pediatrics, 154(4) : e2024066584.
Armstrong D .2021 .Long-term follow-up of children with protracted bacterial bronchitis: Some answers and more questions. Respirology, 26(3) : 218-219.
Ayed K,Khalifa ILH,Mokaddem S,Jameleddine SBK .2020 .Paradoxical bronchoconstriction caused by β(2)- adrenoceptor agonists. Drug Target Insights, 14 : 12-15.
Be'er M,Bushmitz S,Cahal M,Sadot E,Yochpaz S,Besor O,Amirav I,Lavie M .2022 .Asthma risk after a pediatric intensive care unit admission for respiratory syncytial virus bronchiolitis. Pediatr Pulmonol, 57(7) : 1677-1683.
Berry JG,Mansbach JM .2020 .Being mindful about follow-up care after pediatric hospitalization for bronchiolitis. JAMA Pediatr, 174(9) : e201945.
Canto Mangana J,Schilder KA,Bretones-Pedrinaci JI,Blesa ARM,de Medina FS,Martínez-Augustin O,Daddaoua A .2024 .A perspective current and past modes of inhalation therapy. Microb Biotechnol, 17(2) : e14419.
Chen Y,Zhao M,Wu Y,Zang S Y,Glob Y .2020 .Epidemiological analysis of the early 38 fatalities in Hubei, China, of the coronavirus disease 2019. , 10(1) : 011004.
Cheng L,Liu M,Wang R,Cao S,Li R,Su B,Wei H,Yang H,Hou L,Geng C,Han Y,Yang T .2024 .Ambroxol hydrochloride spray (Luo Runchang®) in the treatment of acute respiratory infectious diseases: A prospective, multicenter, open label, randomized controlled study. Front Pediatr, 12 : 1380189.
Daley-Yates P,Singh D,Igea JM,Macchia L,Verma M,Berend N,Plank M .2023 .Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management. , 40(9) : 4042-4059.
Elkomy MH,El Menshawe SF,Kharshoum RM,Abdeltwab AM,Hussein RRS,Hamad DS,Alsalahat I,Aboud HM .2022 .Innovative pulmonary targeting of terbutaline sulfate-laded novasomes for non-invasive tackling of asthma: Statistical optimization and comparative in vitro/in vivo evaluation. Drug Deliv, 29(1) : 2058-2071.
Ferrante G,Piacentini G,Piazza M,Boner AL,Bellanti JA .2024 .Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and postbronchiolitis recurrent wheezing. Allergy Asthma Proc., 45(2) : 84-91.
Fu M,Hu Z,Yu G,Luo Y,Xiong X,Yang Q,Song W,Yu Y,Yang T .2023 .Predictors of extubation failure in newborns: A systematic review and meta-analysis. Ital. J. Pediatr., 49(1) : 133.
Hardy J,Baggott C,Fingleton J,Reddel HK,Hancox RJ,Harwood M,Corin A,Sparks J,Hall D,Sabbagh D,Mane S,Vohlidkova A,Martindale J,Williams M,Shirtcliffe P,Holliday M,Weatherall M,Beasley R M .2019 .Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): A 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet, 394(10202) : 919-928.
Hon KL,Leung AKC,Wong AHC,Dudi A,Leung KKY .2023 .Respiratory Syncytial Virus is the Most Common Causative Agent of Viral Bronchiolitis in Young Children: An Updated Review. Curr. Pediatr. Rev., 19(2) : 139-149.
Huang T,Xia ZF,Li WQ .2021 .Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. Am. J. Otolaryngol., 42(1) : 102820.
Jartti T,Smits HH,Bønnelykke K,Bircan O,Elenius V,Konradsen JR,Maggina P,Makrinioti H,Stokholm J,Hedlin G,Papadopoulos N,Ruszczynski M,Ryczaj K,Schaub B,Schwarze J,Skevaki C,Stenberg-Hammar K,Feleszko W K .2019 .Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments. Allergy, 74(1) : 40-52.
Krings JG,Sekhar TC,Chen V,Blake KV,Sumino K,James AS,Clover AK,Lenze EJ,Brownson RC,Castro M .2023 .Beginning to address an implementation gap in asthma: Clinicians' views of prescribing reliever budesonide-formoterol inhalers and SMART in the United States. J. Allergy Clin. Immunol, 11(9) : 2767-2777.
Lee HJ,Kim HS,Yoon JS .2023 .Impulse oscillometry system for assessing small airway dysfunction in pediatric bronchiolitis obliterans; association with conventional pulmonary function tests. PLoS One, 18(2) : e0280309.
Li M,Bao J,Yang L .2025 .The clinical efficacy of combining ambroxol hydrochloride with antibiotics for the treatment of chronic bronchitis. Altern. Ther. Health Med, 31(1) : 161-167.
Li Y,Williams RJ,Dombrowski ND,Watters K,Daly KP,Irace AL,Visner GA,Rahbar R,Fynn-Thompson F .2020 .Current evaluation and management of plastic bronchitis in the pediatric population. Int. J. Pediatr. Otorhinolaryngol., 130 : 109799.
Lipworth B,Kuo CR,Stewart K,Chan R K .2024 .Budesonide/formoterol or budesonide/albuterol as antiinflammatory reliever therapy for asthma. J. Allergy Clin. Immunol, 12(4) : 889-893.
Liu X,Dong Y,Lv W Y .2024 .Value exploration of treating pediatric pneumonia with ambroxol hydrochloride and procaterol hydrochloride. Minerva Pediatr (Torino), 76(1) : 145-147.
Meng F,Cheng J,Sang P,Wang J .2020 .Effects of bronchoalveolar lavage with ambroxol hydrochloride on treating pulmonary infection in patients with cerebral infarction and on serum proinflammatory cytokines, MDA and SOD. Comput. Math Methods Med, : 7984565.
Murphy KR,Hong JG,Wandalsen G,Larenas-Linnemann D,El Beleidy A,Zaytseva OV,Pedersen SE .2020 .Nebulized inhaled corticosteroids in asthma treatment in children 5 years or younger: A systematic review and global expert analysis. J. Allergy Clin. Immunol, 8(6) : 1815-1827.
O'Riordan TG .2024 .Optimizing aerosolized drug delivery in clinical trials in patients undergoing mechanical ventilation. J. Aerosol. Med, 37(3) : 113-114.
Panettieri RA,Jr. RA,Chipps BE,Skolnik N,George M,Murphy K,Lugogo N K .2024 .The use of albuterol/budesonide as reliever therapy to reduce asthma exacerbations. J. Allergy Clin. Immunol, 12(4) : 882-888.
Patel N,Patel M,Inja R,Krvavac A,Lechner AJ .2021 .Plastic bronchitis in adult and pediatric patients: A review of its presentation, diagnosis and treatment. Mo. Med, 118(4) : 363-373.
Qiu Y,Xu J,Yang Y,Shi Q Y .2022 .Effect of azithromycin combined with ambroxol hydrochloride on immune response to Mycoplasma pneumoniae pneumonia in children. Minerva Pediatr, 74(5) : 626-628.
Shen H,Zhao X,Xu L X .2023 .Meta-analysis of the efficacy of budesonide and ambroxol hydrochloride inhalation in children with pneumonia and their effects on inflammatory response. Hel., 9(11) : e21105.
Smith ME,Gray M,Wilson PT M .2024 .Acceptance and tolerability of helmet cpap in pediatric bronchiolitis and pneumonia: A feasibility study. J. Pediatr. Intensive Care, 13(3) : 296-302.
Sorino C,Negri S,Spanevello A,Visca D,Scichilone N D .2020 .Inhalation therapy devices for the treatment of obstructive lung diseases: The history of inhalers towards the ideal inhaler. Eur. J. Intern. Med, 75 : 15-18.
Strauss RA .2020 .Subcutaneous terbutaline as an alternative to aerosolized albuterol. J. Allergy Clin. Immunol, 8(7) : 2450.
Sultan K,Zamir A,Ashraf W,Imran I,Saeed H,Rehman AU,Majeed A,Rasool MF .2023 .Clinical pharmacokinetics of terbutaline in humans: A systematic review. Naunyn. Schmiedebergs. Arch. Pharmacol., 396(2) : 213-227.
Wopker PM,Schwermer M,Sommer S,Längler A,Fetz K,Ostermann T,Zuzak TJ .2020 .Complementary and alternative medicine in the treatment of acute bronchitis in children: A systematic review. Complement Ther. Med, 49 : 102217.
Wopker PM,Schwermer M,Sommer S,Längler A,Fetz K,Ostermann T,Zuzak TJ .2021 .Expert consensusbased clinical recommendation for an integrative anthroposophic treatment of acute bronchitis in children: A Delphi survey. Complement Ther. Med, 60 : 102736.
Xue A,Zhang H,Song S,Yu X .2024 .Effects of NAcetylcysteine combined with ambroxol hydrochloride on clinical symptoms, CRP and PCT in children with pneumonia. Clinics, 79 : 100476.
Yu F,Li C,Liu M,Shen T,Liu C .2021 .Aerosol inhalation of ambroxol hydrochloride combined with terbutaline can promote recovery of children with severe pneumonia. Am. J. Transl. Res., 13(5) : 5019-5026.
Zhang X,Zhang X,Gu J,Zhang L,Yang R .2024 .The efficacy of nebulized budesonide and ambroxol hydrochloride in treating pediatric community-acquired pneumonia and their impact on clinical characteristics and inflammatory markers. J. Health Popul. Nutr, 43(1) : 132.
Zhu X,Wei Z,Liu X .2023 .Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty. Front Med, 10 : 1182602.
0

Citations

0

Downloads

71

Views